Correction: Reducing the harms of xylazine: clinical approaches, research deficits, and public health context
Saved in:
Main Authors: | Claire M. Zagorski (Author), Rebecca A. Hosey (Author), Christopher Moraff (Author), Aaron Ferguson (Author), Mary Figgatt (Author), Shoshana Aronowitz (Author), Natalie E. Stahl (Author), Lucas G. Hill (Author), Zoe McElligott (Author), Nabarun Dasgupta (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2023-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Reducing the harms of xylazine: clinical approaches, research deficits, and public health context
by: Claire M. Zagorski, et al.
Published: (2023) -
Public health impact and harm reduction implications of xylazine-involved overdoses: a narrative review
by: David T. Zhu
Published: (2023) -
Xylazine co-occurrence with illicit fentanyl is a growing threat in the Deep South: a retrospective study of decedent data
by: William Bradford, et al.
Published: (2024) -
Wastewater Surveillance for Xylazine in Kentucky
by: Chris Delcher, PhD, et al.
Published: (2024) -
Providers' knowledge and perception of xylazine in the unregulated drug supply: a sequential explanatory mixed-methods study
by: Katherine Hill, et al.
Published: (2024)